Feed BPTSY
Summary
No overall score for this company yet.
Valuation -Growth -Profitability -Quality 0Debt 0Stability 68
What speaks for it
- The share price is below the Bulios Fair Price.
What to watch
- It passes only 2 of the 9 points of the Piotroski financial health test.
- For every 100 EUR of bills due within a year it has 25 EUR of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price
Current price $0.25
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Is it growing?
Revenue (EUR)
2020202120222023202420252026
Diluted EPS (EUR)
2020202120222023202420252026
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments 1.21M €
Debt 7.79M €
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.